Aehr Test Systems (AEHR) P/E Ratio History
Deep ValueTrading at -886.9x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1998–2025
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Aehr Test Systems (AEHR) trades at a price-to-earnings ratio of -886.9x, with a stock price of $115.30 and trailing twelve-month earnings per share of $-0.37.
The current P/E is 1381% below its 5-year average of 69.2x. Over the past five years, AEHR's P/E has ranged from a low of 1.9x to a high of 385.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 29.0x, AEHR trades at a 3158% discount to its sector peers. The sector includes 352 companies with P/E ratios ranging from 0.0x to 187.7x.
Relative to the broader market, AEHR trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AEHR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AEHR Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
AEHR P/E vs Peers
Semiconductor Test, Metrology and Inspection Equipment peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $6B | 49.4 | 2.34 | -38% | |
| $17B | 120.1 | 3.47 | -32% | |
| $12B | 216.7 | - | -22% | |
| $6B | 9999.0 | - | +100%Best | |
| $27B | 93.0 | - | +56% | |
| $9B | 187.7 | 13.40 | -57% | |
| $2B | 14.8Lowest | 0.43Best | +9% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
AEHR Historical P/E Data (1998–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | Feb 28 2025 | $9.64 | $0.78 | 12.4x | -86% |
| FY2025 Q2 | Nov 29 2024 | $11.89 | $0.75 | 15.9x | -82% |
| FY2025 Q1 | Aug 30 2024 | $15.21 | $0.99 | 15.4x | -82% |
| FY2024 Q4 | May 31 2024 | $11.51 | $1.12 | 10.3x | -88% |
| FY2024 Q3 | - | $16.27 | $0.52 | 31.4x | -64% |
| FY2024 Q2 | - | $22.96 | $0.71 | 32.4x | -63% |
| FY2024 Q1 | - | $51.01 | $0.63 | 80.6x | -8% |
| FY2023 Q4 | May 31 2023 | $33.02 | $0.50 | 66.6x | -24% |
| FY2023 Q3 | - | $33.35 | $0.49 | 67.8x | -23% |
| FY2023 Q2 | Nov 30 2022 | $26.07 | $0.43 | 60.8x | -31% |
| FY2023 Q1 | Aug 31 2022 | $14.54 | $0.33 | 44.6x | -49% |
| FY2022 Q4 | - | $8.38 | $0.33 | 25.2x | -71% |
| FY2022 Q3 | Feb 28 2022 | $13.60 | $0.15 | 88.3x | +0% |
| FY2022 Q2 | - | $17.42 | $0.05 | 385.4x | +339% |
| FY2020 Q3 | Feb 29 2020 | $2.10 | $0.01 | 256.1x | +192% |
| FY2018 Q4 | - | $2.60 | $0.02 | 115.0x | +31% |
| FY2014 Q4 | May 31 2014 | $2.26 | $0.04 | 63.9x | -27% |
| FY2009 Q2 | Nov 30 2008 | $2.19 | $1.17 | 1.9x | -98% |
| FY2009 Q1 | Aug 31 2008 | $4.37 | $1.23 | 3.6x | -96% |
| FY2008 Q4 | May 31 2008 | $8.70 | $1.22 | 7.1x | -92% |
| FY2008 Q3 | Feb 29 2008 | $7.30 | $0.59 | 12.4x | -86% |
| FY2008 Q2 | Nov 30 2007 | $6.03 | $0.39 | 15.5x | -82% |
| FY2008 Q1 | Aug 31 2007 | $6.90 | $0.31 | 22.3x | -75% |
| FY2007 Q4 | - | $6.05 | $0.29 | 20.9x | -76% |
| FY2007 Q3 | Feb 28 2007 | $5.91 | $0.24 | 24.3x | -72% |
| FY2007 Q2 | - | $4.96 | $0.26 | 18.9x | -79% |
| FY2007 Q1 | - | $9.97 | $0.20 | 49.1x | -44% |
| FY2006 Q4 | May 31 2006 | $6.43 | $0.10 | 64.0x | -27% |
| FY1999 Q2 | Nov 30 1998 | $4.50 | $0.00 | 1071.4x | +1120% |
| FY1999 Q1 | Aug 31 1998 | $4.44 | $0.20 | 22.7x | -74% |
| FY1998 Q4 | May 31 1998 | $6.06 | $0.37 | 16.5x | -81% |
Average P/E for displayed period: 87.8x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AEHR — Frequently Asked Questions
Quick answers to the most common questions about buying AEHR stock.
What is AEHR's P/E ratio?
Aehr Test Systems (AEHR) trailing twelve-month P/E ratio is -886.9x, based on TTM diluted EPS of $-0.37. The 5-year average P/E is 69.2x and the historical range spans 1.9x to 385.4x.
Is AEHR stock overvalued or undervalued?
AEHR trades at -886.9x P/E, below its 5-year average of 69.2x. At the 0th percentile of its historical range (1.9x–385.4x), the stock is priced at a discount to its own history.
Is AEHR stock expensive?
No, AEHR is not expensive on a historical basis. The current P/E of -886.9x is below the 5-year average of 69.2x and sits at the 0th percentile of its valuation range.
What is AEHR's historical P/E range?
Over the past 5 years, AEHR's P/E ratio has ranged from 1.9x to 385.4x, with a median of 44.6x and an average of 69.2x. The current P/E of -886.9x places the stock at the 0th percentile of this range. Full historical data spans 1998–2025.
How does AEHR's P/E compare to the S&P 500?
AEHR trades at -886.9x P/E versus the S&P 500 median of 24.4x. The 3735% discount to the market suggests lower growth expectations or perceived higher risk.
How does AEHR's valuation compare to Technology peers?
Aehr Test Systems P/E of -886.9x compares to the Technology sector median of 29.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is AEHR's PEG ratio?
AEHR PEG ratio is N/A, based on a P/E of -886.9x and EPS growth of 0.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is AEHR's earnings yield?
AEHR earnings yield is N/A, the inverse of its -886.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.